S. Nagpal, S. Patel, H. Jacobe, D. Disepio, C. Ghosn et al., Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin, J Invest Dermatol, vol.109, pp.91-96, 1997.

V. Wittamer, J. D. Franssen, M. Vulcano, J. F. Mirjolet, L. Poul et al., Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids, J Exp Med, vol.198, pp.977-85, 2003.

B. A. Zabel, A. M. Silverio, and E. C. Butcher, Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood, J Immunol, vol.174, pp.244-51, 2005.

K. B. Goralski, T. C. Mccarthy, E. A. Hanniman, B. A. Zabel, E. C. Butcher et al., Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism, J Biol Chem, vol.282, pp.28175-88, 2007.

S. Luangsay, V. Wittamer, B. Bondue, D. Henau, O. Rouger et al., Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model, J Immunol, vol.183, pp.6489-99, 2009.

V. Wittamer, F. Gregoire, P. Robberecht, G. Vassart, D. Communi et al., The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency, J Biol Chem, vol.279, pp.9956-62, 2004.

V. Wittamer, B. Bondue, A. Guillabert, G. Vassart, M. Parmentier et al., Neutrophil-mediated maturation of chemerin: a link between innate and adaptive immunity, J Immunol, vol.175, pp.487-93, 2005.

B. A. Zabel, S. J. Allen, P. Kulig, J. A. Allen, J. Cichy et al., Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades, J Biol Chem, vol.280, pp.34661-34667, 2005.

K. Bozaoglu, J. E. Curran, C. J. Stocker, M. S. Zaibi, D. Segal et al., Chemerin, a novel adipokine in the regulation of angiogenesis, J Clin Endocrinol Metab, vol.95, pp.2476-85, 2010.

M. Samson, A. L. Edinger, P. Stordeur, J. Rucker, V. Verhasselt et al., ChemR23, a putative chemoattractant receptor, is expressed in monocytederived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains, Eur J Immunol, vol.28, pp.1689-700, 1998.

S. Parolini, A. Santoro, E. Marcenaro, W. Luini, L. Massardi et al., The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues, Blood, vol.109, pp.3625-3657, 2007.

K. Bozaoglu, K. Bolton, J. Mcmillan, P. Zimmet, J. Jowett et al., Chemerin is a novel adipokine associated with obesity and metabolic syndrome, Endocrinology, vol.148, pp.4687-94, 2007.

J. Kaur, R. Adya, B. K. Tan, J. Chen, and H. S. Randeva, Identification of chemerin receptor (ChemR23) in human endothelial cells: chemerin-induced endothelial angiogenesis, Biochem Biophys Res Commun, vol.391, pp.1762-1770, 2010.

H. Sell, J. Laurencikiene, A. Taube, K. Eckardt, A. Cramer et al., Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells, Diabetes, vol.58, pp.2731-2771, 2009.

A. J. Kennedy and A. P. Davenport, International Union of Basic and Clinical Pharmacology CIII: chemerin receptors CMKLR1 (chemerin1) and GPR1 (chemerin2) nomenclature, pharmacology, and function, Pharmacol Rev, vol.70, pp.174-96, 2018.

B. A. Zabel, S. Nakae, L. Zuniga, J. Y. Kim, T. Ohyama et al., Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis, J Exp Med, vol.205, pp.2207-2227, 2008.

A. Marchese, J. M. Docherty, T. Nguyen, M. Heiber, R. Cheng et al., Cloning of human genes encoding novel G proteincoupled receptors, Genomics, vol.23, pp.609-627, 1994.

M. Reverchon, M. Cornuau, C. Rame, F. Guerif, D. Royere et al., Chemerin inhibits IGF-1-induced progesterone and estradiol secretion in human granulosa cells, Hum Reprod, vol.27, pp.1790-800, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01129643

M. Banas, A. Zegar, M. Kwitniewski, K. Zabieglo, J. Marczynska et al., The expression and regulation of chemerin in the epidermis, PLoS ONE, vol.10, p.117830, 2015.

G. Barnea, W. Strapps, G. Herrada, Y. Berman, J. Ong et al., The genetic design of signaling cascades to record receptor activation

, Proc Natl Acad Sci USA, vol.105, pp.64-73, 2008.

D. Henau, O. Degroot, G. N. Imbault, V. Robert, V. et al., Atypical chemokine receptors and their roles in the resolution of the inflammatory response, Front Immunol, vol.11, p.224, 2016.

K. Otero, A. Vecchi, E. Hirsch, J. Kearley, W. Vermi et al., Nonredundant role of CCRL2 in lung dendritic cell trafficking, Blood, vol.116, pp.2942-2951, 2010.

J. Monnier, S. Lewen, E. O'hara, K. Huang, H. Tu et al., Expression, regulation, and function of atypical chemerin receptor CCRL2 on endothelial cells, J Immunol, vol.189, pp.956-67, 2012.

R. Hart and D. R. Greaves, Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5, J Immunol, vol.185, pp.3728-3767, 2010.

C. Albanesi, C. Scarponi, S. Pallotta, D. R. Bosisio, D. Madonna et al., Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment, J Exp Med, vol.206, pp.249-58, 2009.

K. L. Graham, B. A. Zabel, S. Loghavi, L. A. Zuniga, P. P. Ho et al., Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease, J Immunol, vol.183, pp.6717-6740, 2009.

T. Demoor, K. R. Bracke, L. L. Dupont, M. Plantinga, B. Bondue et al., The role of ChemR23 in the induction and resolution of cigarette smoke-induced inflammation, J Immunol, vol.186, pp.5457-67, 2011.

B. Bondue, O. Vosters, P. De-nadai, S. Glineur, D. Henau et al., ChemR23 dampens lung inflammation and enhances anti-viral immunity in a mouse model of acute viral pneumonia, PLoS Pathog, vol.7, 2011.

S. Provoost, D. Grove, K. C. Fraser, G. L. Lannoy, V. J. Tournoy et al., Pro-and anti-inflammatory role of ChemR23 signaling in pollutantinduced inflammatory lung responses, J Immunol, vol.196, pp.1882-90, 2016.

M. Lehrke, A. Becker, M. Greif, R. Stark, R. P. Laubender et al., Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis, Eur J Endocrinol, vol.161, pp.339-383, 2009.

W. J. Shin, B. A. Zabel, and R. K. Pachynski, Mechanisms and functions of chemerin in cancer: potential roles in therapeutic intervention, Front Immunol, vol.9, p.2772, 2018.

C. Wang, W. K. Wu, X. Liu, K. F. To, G. G. Chen et al., Increased serum chemerin level promotes cellular invasiveness in gastric cancer: a clinical and experimental study, Peptides, vol.51, pp.131-139, 2014.

S. Erdogan, F. M. Yilmaz, O. Yazici, A. Yozgat, S. Sezer et al., Inflammation and chemerin in colorectal cancer, Tumour Biol, vol.37, pp.6337-6379, 2016.

Y. Yamaguchi, X. Y. Du, L. Zhao, J. Morser, and L. L. Leung, Proteolytic cleavage of chemerin protein is necessary for activation to the active form, Chem157S, which functions as a signaling molecule in glioblastoma, J Biol Chem, vol.286, pp.39510-39519, 2011.

Y. Zheng, S. Luo, G. Wang, Z. Peng, W. Zeng et al., Downregulation of tazarotene induced gene-2 (TIG2) in skin squamous cell carcinoma, Eur J Dermatol, vol.18, pp.638-679, 2008.

R. K. Pachynski, B. A. Zabel, H. E. Kohrt, N. M. Tejeda, J. Monnier et al., The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses, J Exp Med, vol.209, pp.1427-1462, 2012.

W. Lin, Y. L. Chen, L. Jiang, and J. K. Chen, Reduced expression of chemerin is associated with a poor prognosis and a lowed infiltration of both dendritic cells and natural killer cells in human hepatocellular carcinoma, Clin Lab, vol.57, pp.879-85, 2011.

D. Hanahan and L. M. Coussens, Accessories to the crime: functions of cells recruited to the tumor microenvironment, Cancer Cell, vol.21, pp.309-331, 2012.

I. Diamond, T. Owolabi, M. Marco, C. Lam, and A. Glick, Conditional gene expression in the epidermis of transgenic mice using the tetracyclineregulated transactivators tTA and rTA linked to the keratin 5 promoter, J Invest Dermatol, vol.115, pp.788-94, 2000.

E. L. Abel, J. M. Angel, K. Kiguchi, and J. Digiovanni, Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications, Nat Protoc, vol.4, pp.1350-62, 2009.

G. Petter and U. F. Haustein, Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma, Dermatol Surg, vol.26, pp.521-551, 2000.

C. J. Kemp, Multistep skin cancer in mice as a model to study the evolution of cancer cells, Semin Cancer Biol, vol.15, pp.460-73, 2005.

J. E. Rundhaug and S. M. Fischer, Molecular mechanisms of mouse skin tumor promotion, Cancers, vol.2, pp.436-82, 2010.

B. Bondue, V. Wittamer, and M. Parmentier, Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism, Cytokine Growth Factor Rev, vol.22, pp.331-339, 2011.

J. K. Kundu and Y. J. Surh, Inflammation: gearing the journey to cancer, Mutat Res, vol.659, pp.15-30, 2008.

S. I. Grivennikov, F. R. Greten, and M. Karin, Immunity, inflammation, and cancer. Cell, vol.140, pp.883-99, 2010.

L. Zhao, Y. Yamaguchi, W. J. Shen, J. Morser, and L. Leung, Dynamic and tissue-specific proteolytic processing of chemerin in obese mice, PLoS ONE, vol.13, p.202780, 2018.

J. L. Rourke, H. J. Dranse, and C. J. Sinal, CMKLR1 and GPR1 mediate chemerin signaling through the RhoA/ROCK pathway, Mol Cell Endocrinol, vol.417, pp.36-51, 2015.

J. D. Kumar, I. Aolymat, L. Tiszlavicz, Z. Reisz, H. M. Garalla et al., Chemerin acts via CMKLR1 and GPR1 to stimulate migration and invasion of gastric cancer cells: putative role of decreased TIMP-1 and TIMP-2, Oncotarget, vol.10, pp.98-112, 2019.

T. F. Gajewski, H. Schreiber, and Y. X. Fu, Innate and adaptive immune cells in the tumor microenvironment, Nat Immunol, vol.14, pp.1014-1036, 2013.

W. Vermi, E. Riboldi, V. Wittamer, F. Gentili, W. Luini et al., Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin, J Exp Med, vol.201, pp.509-524, 2005.

Y. Song, W. Yin, Y. Dan, J. Sheng, Y. Zeng et al., Chemerin partly mediates tumor-inhibitory effect of all-trans retinoic acid via CMKLR1-dependent natural killer cell recruitment, Immunology, vol.157, pp.248-56, 2019.

K. W. Christopherson, . Ii, J. J. Campbell, and R. A. Hromas, Transgenic overexpression of the CC chemokine CCL21 disrupts T-cell migration, Blood, vol.98, pp.3562-3570, 2001.

Y. Liu-chittenden, M. Jain, K. Gaskins, S. Wang, M. J. Merino et al., RARRES2 functions as a tumor suppressor by promoting beta-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma, Oncogene, vol.36, pp.3541-52, 2017.

N. Nakamura, K. Naruse, Y. Kobayashi, M. Miyabe, T. Saiki et al., Chemerin promotes angiogenesis in vivo, Physiol Rep, vol.6, p.13962, 2018.

P. Kulig, T. Kantyka, B. A. Zabel, M. Banas, A. Chyra et al., Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins, J Immunol, vol.187, pp.1403-1413, 2011.